
Buy B7-33 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy B7-33 Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Next batch coming soon
This compound is temporarily out of stock. Check back soon or contact us for a restock estimate.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Next batch coming soon
This compound is temporarily out of stock. Check back soon or contact us for a restock estimate.
Verify Batch
Lot-level COA, Batch DF/B73/062026
What is B7-33?
B7-33 is a single-chain synthetic peptide based on the B-chain of human relaxin-2, designed to keep relaxin's anti-scarring and blood-vessel signaling while being easier to make. It is studied in animal research for its effects on tissue scarring in the heart, lungs, kidneys and liver.
- Based on human relaxin-2, studied for relaxin-receptor signaling similar to the full hormone
- Studied in animal research for its effects on tissue scarring and collagen buildup in organs
- Investigated in three rodent models of organ scarring, with activity comparable to the parent hormone
- Works on pathways involved in remodeling the tissue scaffold and turning over collagen
For research use only. Not approved for human therapeutic use.
B7-33 is a synthetic single-chain peptide analog of human relaxin-2 with a molecular weight of 2987.75 g/mol. Its structure corresponds to residues 7 through 33 of the B-chain of relaxin-2, a 27-amino acid linear fragment that retains the receptor-binding determinants for the relaxin family peptide receptor 1 (RXFP1) while eliminating the two-chain disulfide-linked architecture of the native heterodimeric relaxin-2 hormone. B7-33 was designed as a simplified, single-chain alternative that maintains RXFP1 binding and activation. Produced via solid-phase peptide synthesis, B7-33 is associated with RXFP1-mediated signaling and extracellular matrix remodeling pathways.
B7-33 is a structurally simplified relaxin-2 mimetic that overcomes the challenges associated with the native two-chain disulfide hormone. In vitro studies have characterized B7-33 as a functionally selective agonist of RXFP1: it binds the receptor with lower affinity than native H2 relaxin and is only a weak activator of the cAMP pathway, yet it drives ERK1/2 phosphorylation with potency comparable to H2 relaxin in cells that natively express RXFP1, and increases expression of the collagen-degrading enzyme matrix metalloproteinase-2 (MMP-2) in human cardiac fibroblasts and rat renal myofibroblasts [1]. In vivo rodent studies have shown that B7-33 prevented or reversed organ fibrosis and dysfunction with potency similar to H2 relaxin across three preclinical rodent models, and that an acute bolus of B7-33 reproduced the rapid vasoprotective/vascular-function effects of serelaxin selectively in the rat mesenteric artery, with no such effect observed in the small renal artery or abdominal aorta [1][2], making B7-33 a reference compound in preclinical cardiovascular and fibrosis research examining single-chain, functionally selective RXFP1 agonism and pERK1/2–MMP-2-directed extracellular matrix remodeling in rodent models.
B7-33 is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Related Compounds
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






